Table 3.

Two-year clinical outcomes.

	Before PSM			After PSM
	LMCA (n = 155)	Non-LMCA (n = 6274)	p value	LMCA (n = 150)	Non-LMCA (n = 150)	p value
All-cause death	4 (2.6)	82 (1.3)	0.153	3 (2.0)	2 (1.3)	1.000
Cardiac death	4 (2.6)	47 (0.7)	0.034	3 (2.0)	0 (0)	0.247
Myocardial infarction	11 (7.1)	116 (1.8)	<0.001	11 (3.0)	2 (1.3)	0.011
Target vessel related	8 (5.2)	52 (0.8)	<0.001	8 (5.3)	3 (2.0)	0.125
Target lesion related	2 (1.3)	31 (0.5)	0.188	2 (1.3)	1 (0.7)	1.000
Unplanned revascularization	10 (6.5)	546 (8.7)	0.325	10 (6.7)	15 (10.0)	0.296
Target vessel related	9 (5.8)	146 (94.2)	0.722	9 (6.0)	9 (6.0)	1.000
Target lesion related	7 (4.5)	148 (95.5)	0.755	7 (4.7)	7 (4.7)	1.000
In-stent thrombosis	7 (4.5)	51 (0.8)	<0.001	6 (4.0)	2 (1.3)	0.282
Stroke	6 (3.9)	88 (1.4)	0.025	5 (3.3)	6 (4.0)	0.759
Bleeding	11 (7.1)	401 (6.4)	0.723	11 (7.3)	6 (4.0)	0.212
MACCE	24 (15.5)	768 (12.2)	0.225	22 (14.7)	23 (15.3)	0.872

MACCE = major adverse cardiac and cerebrovascular events.